A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant <it>Klebsiella pneumoniae</it> infection
<p>Abstract</p> <p>Background</p> <p>Healthcare-associated infections caused by <it>Klebsiella pneumoniae</it> isolates are increasing and few effective antibiotics are currently available to treat patients. We observed decreased carbapenem susceptibility am...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-02-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2334/13/80 |
id |
doaj-7e9060b0c2434fcda179d440112eafe8 |
---|---|
record_format |
Article |
spelling |
doaj-7e9060b0c2434fcda179d440112eafe82020-11-25T03:40:26ZengBMCBMC Infectious Diseases1471-23342013-02-011318010.1186/1471-2334-13-80A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant <it>Klebsiella pneumoniae</it> infectionCorrea LuciMartino Marines Dalla ValleSiqueira ItacyPasternak JacyrGales Ana CristinaSilva Claudia ValloneCamargo Thiago Zinsly SampaioScherer Patricia FariaMarra Alexandre Rodrigues<p>Abstract</p> <p>Background</p> <p>Healthcare-associated infections caused by <it>Klebsiella pneumoniae</it> isolates are increasing and few effective antibiotics are currently available to treat patients. We observed decreased carbapenem susceptibility among <it>K. pneumoniae</it> isolated from patients at a tertiary private hospital that showed a phenotype compatible with carbapenemase production although this group of enzymes was not detected in any sample. The aim of this study was to describe the epidemiology and clinical outcomes associated with carbapenem-resistant <it>K. pneumoniae</it> and to determine the antimicrobial resistance mechanisms.</p> <p>Methods</p> <p>Risk factors associated with carbapenem-resistant <it>K. pneumoniae</it> infections were investigated by a matched case–control study from January 2006 through August 2008. A cohort study was also performed to evaluate the association between carbapenem resistance and in-hospital mortality. Bacterial identification and antimicrobial susceptibility were determined by Vitek 2 and Etest. Carbapenemase activity was detected using spectrophotometric assays. Production of beta-lactamases and alterations in genes encoding <it>K. pneumoniae</it> outer membrane proteins, OmpK35 and OmpK36, were analyzed by PCR and DNA sequencing, as well as SDS-Page. Genetic relatedness of carbapenem resistant isolates was evaluated by Pulsed Field Gel Electrophoresis.</p> <p>Results</p> <p>Sixty patients were included (20 cases and 40 controls) in the study. Mortality was higher for patients with carbapenem-resistant <it>K. pneumoniae</it> infections compared with those with carbapenem-susceptible <it>K. pneumoniae</it> (50.0% vs 25.7%). The length of central venous catheter use was independently associated with carbapenem resistance in the multivariable analysis. All strains, except one, carried <it>bla</it><sub>CTX-M-2,</sub> an extended-spectrum betalactamase gene. In addition, a single isolate also possessed <it>bla</it><sub>GES-1.</sub> Genes encoding plasmid-mediated AmpC beta-lactamases or carbapenemases (KPC, metallo-betalactamases or OXA-carbapenemases) were not detected.</p> <p>Conclusions</p> <p>The <it>K. pneumoniae</it> multidrug-resistant organisms were associated with significant mortality. The mechanisms associated with decreased <it>K. pneumoniae</it> carbapenem susceptibility were likely due to the presence of cephalosporinases coupled with porin alterations, which resulted from the presence of the insertion sequences in the outer membrane encoding genes.</p> http://www.biomedcentral.com/1471-2334/13/80Klebsiella pneumoniaeCarbapenem-resistant <it>Klebsiella</it>Healthcare associated infections<it>Klebsiella</it> infections/microbiology<it>Klebsiella</it> infections/mortality |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Correa Luci Martino Marines Dalla Valle Siqueira Itacy Pasternak Jacyr Gales Ana Cristina Silva Claudia Vallone Camargo Thiago Zinsly Sampaio Scherer Patricia Faria Marra Alexandre Rodrigues |
spellingShingle |
Correa Luci Martino Marines Dalla Valle Siqueira Itacy Pasternak Jacyr Gales Ana Cristina Silva Claudia Vallone Camargo Thiago Zinsly Sampaio Scherer Patricia Faria Marra Alexandre Rodrigues A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant <it>Klebsiella pneumoniae</it> infection BMC Infectious Diseases Klebsiella pneumoniae Carbapenem-resistant <it>Klebsiella</it> Healthcare associated infections <it>Klebsiella</it> infections/microbiology <it>Klebsiella</it> infections/mortality |
author_facet |
Correa Luci Martino Marines Dalla Valle Siqueira Itacy Pasternak Jacyr Gales Ana Cristina Silva Claudia Vallone Camargo Thiago Zinsly Sampaio Scherer Patricia Faria Marra Alexandre Rodrigues |
author_sort |
Correa Luci |
title |
A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant <it>Klebsiella pneumoniae</it> infection |
title_short |
A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant <it>Klebsiella pneumoniae</it> infection |
title_full |
A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant <it>Klebsiella pneumoniae</it> infection |
title_fullStr |
A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant <it>Klebsiella pneumoniae</it> infection |
title_full_unstemmed |
A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant <it>Klebsiella pneumoniae</it> infection |
title_sort |
hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant <it>klebsiella pneumoniae</it> infection |
publisher |
BMC |
series |
BMC Infectious Diseases |
issn |
1471-2334 |
publishDate |
2013-02-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Healthcare-associated infections caused by <it>Klebsiella pneumoniae</it> isolates are increasing and few effective antibiotics are currently available to treat patients. We observed decreased carbapenem susceptibility among <it>K. pneumoniae</it> isolated from patients at a tertiary private hospital that showed a phenotype compatible with carbapenemase production although this group of enzymes was not detected in any sample. The aim of this study was to describe the epidemiology and clinical outcomes associated with carbapenem-resistant <it>K. pneumoniae</it> and to determine the antimicrobial resistance mechanisms.</p> <p>Methods</p> <p>Risk factors associated with carbapenem-resistant <it>K. pneumoniae</it> infections were investigated by a matched case–control study from January 2006 through August 2008. A cohort study was also performed to evaluate the association between carbapenem resistance and in-hospital mortality. Bacterial identification and antimicrobial susceptibility were determined by Vitek 2 and Etest. Carbapenemase activity was detected using spectrophotometric assays. Production of beta-lactamases and alterations in genes encoding <it>K. pneumoniae</it> outer membrane proteins, OmpK35 and OmpK36, were analyzed by PCR and DNA sequencing, as well as SDS-Page. Genetic relatedness of carbapenem resistant isolates was evaluated by Pulsed Field Gel Electrophoresis.</p> <p>Results</p> <p>Sixty patients were included (20 cases and 40 controls) in the study. Mortality was higher for patients with carbapenem-resistant <it>K. pneumoniae</it> infections compared with those with carbapenem-susceptible <it>K. pneumoniae</it> (50.0% vs 25.7%). The length of central venous catheter use was independently associated with carbapenem resistance in the multivariable analysis. All strains, except one, carried <it>bla</it><sub>CTX-M-2,</sub> an extended-spectrum betalactamase gene. In addition, a single isolate also possessed <it>bla</it><sub>GES-1.</sub> Genes encoding plasmid-mediated AmpC beta-lactamases or carbapenemases (KPC, metallo-betalactamases or OXA-carbapenemases) were not detected.</p> <p>Conclusions</p> <p>The <it>K. pneumoniae</it> multidrug-resistant organisms were associated with significant mortality. The mechanisms associated with decreased <it>K. pneumoniae</it> carbapenem susceptibility were likely due to the presence of cephalosporinases coupled with porin alterations, which resulted from the presence of the insertion sequences in the outer membrane encoding genes.</p> |
topic |
Klebsiella pneumoniae Carbapenem-resistant <it>Klebsiella</it> Healthcare associated infections <it>Klebsiella</it> infections/microbiology <it>Klebsiella</it> infections/mortality |
url |
http://www.biomedcentral.com/1471-2334/13/80 |
work_keys_str_mv |
AT correaluci ahospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT martinomarinesdallavalle ahospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT siqueiraitacy ahospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT pasternakjacyr ahospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT galesanacristina ahospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT silvaclaudiavallone ahospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT camargothiagozinslysampaio ahospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT schererpatriciafaria ahospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT marraalexandrerodrigues ahospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT correaluci hospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT martinomarinesdallavalle hospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT siqueiraitacy hospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT pasternakjacyr hospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT galesanacristina hospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT silvaclaudiavallone hospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT camargothiagozinslysampaio hospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT schererpatriciafaria hospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection AT marraalexandrerodrigues hospitalbasedmatchedcasecontrolstudytoidentifyclinicaloutcomeandriskfactorsassociatedwithcarbapenemresistantitklebsiellapneumoniaeitinfection |
_version_ |
1724534926665056256 |